Co-Authors
This is a "connection" page, showing publications co-authored by Franck Touret and Bruno Coutard.
Connection Strength
1.125
-
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020 08 04; 10(1):13093.
Score: 0.896
-
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021 03 19; 12(1):1735.
Score: 0.058
-
Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(E)-2-Methyl-but-2-Enyl Nucleoside Phosphonate Prodrugs. Molecules. 2021 Mar 09; 26(5).
Score: 0.058
-
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. Nat Commun. 2020 09 17; 11(1):4682.
Score: 0.056
-
Drugs against SARS-CoV-2: What do we know about their mode of action? Rev Med Virol. 2020 11; 30(6):1-10.
Score: 0.056